A new study published in the journal of Respiratory Medicine showed that patients with type 2 inflammation and chronic ...

Summary. Exacerbations of COPD are common and can be detrimental to both patient health and health care costs. Corticosteroids are recommended by consensus guidelines for patients during ...

Loneliness is a key risk factor for symptom exacerbations and hospitalizations in people with COPD, highlighting the need for ...

Aim The bacterial and atypical etiology of acute exacerbations of chronic obstructive pulmonary disease was investigated and the diagnostic techniques used were compared among 92 hospitalized ...

Biometry Inc. (myBiometry), an asthma and COPD diagnostic and remote monitoring company, announced that it has successfully ...

Researchers are exploring how small airway abnormalities in younger smokers could help identify who is at risk of developing ...

Delhi's air pollution has reached severe levels, raising health concerns for those with chronic respiratory diseases like ...

Researchers are exploring how small airway abnormalities in younger smokers could help identify who is at risk of developing ...

This roundup offers a look at the latest insights from the clinicians and researchers investigating chronic obstructive pulmonary disease and asthma.

particularly among those suffering from asthma and COPD (chronic obstructive pulmonary disease). Pulmonologist Dr Himanshu ...

The BOREAS Phase III trial showed DUPIXENT reduced exacerbations by 30% and improved lung function by 160 mL at 52 weeks.

Type 2 inflammation is identified as a primary cause in 80% of asthma cases and 30%-40% of COPD cases. The data obtained from ...